Cargando…
Adipokines as Immune Cell Modulators in Multiple Sclerosis
Multiple sclerosis (MS), a chronic inflammatory and demyelinating disease of the central nervous system (CNS), is a major clinical and societal problem, which has a tremendous impact on the life of patients and their proxies. Current immunomodulatory and anti-inflammatory therapies prove to be relat...
Autores principales: | Rijnsburger, Merel, Djuric, Niek, Mulder, Inge A., de Vries, Helga E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509121/ https://www.ncbi.nlm.nih.gov/pubmed/34639186 http://dx.doi.org/10.3390/ijms221910845 |
Ejemplares similares
-
Adipokines in multiple sclerosis patients are related to clinical and radiological measures
por: Loonstra, Floor C., et al.
Publicado: (2022) -
Reduced Angiopoietin-Like 4 Expression in Multiple Sclerosis Lesions Facilitates Lipid Uptake by Phagocytes via Modulation of Lipoprotein-Lipase Activity
por: Kamermans, Alwin, et al.
Publicado: (2019) -
Multiple Sclerosis and Obesity: Possible Roles of Adipokines
por: Guerrero-García, José de Jesús, et al.
Publicado: (2016) -
Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis
por: Rodríguez-Lorenzo, Sabela, et al.
Publicado: (2020) -
Multiple sclerosis and obesity: The role of adipokines
por: Correale, Jorge, et al.
Publicado: (2022)